PARIS, May 29, 2017 /PRNewswire/ --
Novomed Group, France's leader in the marketof disposable medical kits, is happy to announce the acquisition of 100% of Mediq France's shares, bought from Dutch Company, Mediq.
(Logo: http://mma.prnewswire.com/media/515167/Novomed_Group_Logo.jpg )
Through this acquisition,
Hervé Liebermann, Novomed Group CEO, said: "There's an obvious complementarity between our Companies that this strategic acquisition provides: complementarity between Novomed's production & sourcing expertise and Mediq's mastery of online distribution on the one hand, and complementarity between our clienteles (hospitals and independent practitioners) on the other. This marriage will help us to build a French medical materials champion capable of accelerating its digital transition and its international development."
Mediq France Management will continue to exist after the merging of the two companies into one Group.
Aurélie Descubes, Mediq France CEO, added, "Mediq France has succeeded in implementing major changes in its organization to address our customers' needs more efficiently. Our joining up with Novomed Group gives us the opportunity to move forward. With more than 100 000 clients in France and in Europe, the group will be unique in the innovation of its products and its service offering. With this in mind, our ability to continue our rapid growth in the digital field will be vital to achieve our strategic goals.
The operation was financed by senior and junior mezzanine debt arranged by Capzanine and through bank syndication including LCL, BNP Paribas and Caisse d'Epargne Ile-de-France, cofinanced by BPIfrance. The financial due-diligence was carried out by Aca Nexia, while PGA acted as legal advisors and D&A as financial advisors for Novomed Group's shareholders. Mediq Group was advised by Jones Day.
Established in 1993, Novomed Group is specialized in the conception, manufacturing and distribution of disposable medical kits that have become key tools in the fight against healthcare-associated or hospital-acquired infections.
France's leader in the gynecological-obstetrical and aesthetical-dermatological segments through its business units "Laboratoire Gyneas" and "Laboderm", the Group has been driven by a strong innovative and entrepreneurial spirit since its foundation. Novomed has developed other business units such as the cosmetics brand Moraz, the cosmetotextile lines Beautyline and Arnitex and the range of comfort products for senior citizens Novo'Life.
SOURCE Novomed Group
Subscribe to our Free Newsletters!
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All